Fabrice Carrat

Author PubWeight™ 120.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890. J Hepatol 2013 5.64
2 Risk factors of influenza transmission in households. Br J Gen Pract 2004 5.25
3 Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet 2009 5.03
4 Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N Engl J Med 2011 4.39
5 Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology 2011 3.08
6 Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology 2013 2.78
7 Influenza epidemics in the United States, France, and Australia, 1972-1997. Emerg Infect Dis 2004 2.37
8 Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections. J Hepatol 2005 2.26
9 Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy. Gut 2010 1.98
10 Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis. Hepatology 2012 1.92
11 Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study. Gut 2010 1.87
12 Effect of influenza vaccination of nursing home staff on mortality of residents: a cluster-randomized trial. J Am Geriatr Soc 2009 1.87
13 Prediction of the spread of influenza epidemics by the method of analogues. Am J Epidemiol 2003 1.85
14 Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial. JAMA 2011 1.83
15 Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV. AIDS 2006 1.76
16 Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey. Blood 2012 1.73
17 The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology 2005 1.67
18 Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS. Chest 2012 1.66
19 Liver biopsy: the best, not the gold standard. J Hepatol 2008 1.65
20 Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients. Gastroenterology 2002 1.56
21 Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection. J Hepatol 2010 1.51
22 Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic. BMC Infect Dis 2010 1.48
23 Mortality burden of the 1918-1919 influenza pandemic in Europe. Influenza Other Respir Viruses 2009 1.35
24 Online detection and quantification of epidemics. BMC Med Inform Decis Mak 2007 1.33
25 Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic. PLoS One 2012 1.29
26 Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso. Am J Trop Med Hyg 2010 1.28
27 Transmissibility and geographic spread of the 1889 influenza pandemic. Proc Natl Acad Sci U S A 2010 1.22
28 Population modeling of influenza A/H1N1 virus kinetics and symptom dynamics. J Virol 2010 1.14
29 Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors. AIDS 2006 1.13
30 Surgical mask to prevent influenza transmission in households: a cluster randomized trial. PLoS One 2010 1.13
31 Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study. Am J Hematol 2014 1.10
32 Explaining rapid reinfections in multiple-wave influenza outbreaks: Tristan da Cunha 1971 epidemic as a case study. Proc Biol Sci 2011 1.10
33 Performance of rapid tests for detection of HBsAg and anti-HBsAb in a large cohort, France. J Hepatol 2012 1.09
34 The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model. Value Health 2007 1.08
35 Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis. J Hepatol 2011 1.06
36 Predicting pneumonia and influenza mortality from morbidity data. PLoS One 2007 1.05
37 Chronic hepatitis C virus infection: does it really impact health-related quality of life? A study in rural Egypt. Hepatology 2004 1.04
38 Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02. J Hepatol 2008 1.04
39 Pandemic influenza due to pH1N1/2009 virus: estimation of infection burden in Reunion Island through a prospective serosurvey, austral winter 2009. PLoS One 2011 1.03
40 Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role? J Acquir Immune Defic Syndr 2007 1.02
41 Broad respiratory virus detection in infants hospitalized for bronchiolitis by use of a multiplex RT-PCR DNA microarray system. J Med Virol 2012 1.02
42 Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY). AIDS 2007 1.01
43 Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression. Hepatology 2013 0.99
44 Cost effectiveness of fibrosis assessment prior to treatment for chronic hepatitis C patients. PLoS One 2011 0.98
45 Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy. J Acquir Immune Defic Syndr 2005 0.98
46 Incidence, presentation, and prognosis of small bowel adenocarcinoma in patients with small bowel Crohn's disease: a prospective observational study. Inflamm Bowel Dis 2013 0.96
47 Rapid and early virological response to chronic hepatitis C treatment with IFN alpha2b or PEG-IFN alpha2b plus ribavirin in HIV/HCV co-infected patients. Gut 2007 0.96
48 How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited. Clin Chem 2008 0.96
49 Detection of lung cancer on radiographs: receiver operating characteristic analyses of radiologists', pulmonologists', and anesthesiologists' performance. Radiology 2004 0.96
50 Integrative study of pandemic A/H1N1 influenza infections: design and methods of the CoPanFlu-France cohort. BMC Public Health 2012 0.96
51 Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France. PLoS One 2011 0.94
52 Intense co-circulation of non-influenza respiratory viruses during the first wave of pandemic influenza pH1N1/2009: a cohort study in Reunion Island. PLoS One 2012 0.93
53 Exploring cross-protection between influenza strains by an epidemiological model. Virus Res 2004 0.93
54 Assessment and determinants of aesthetic discomfort in hand osteoarthritis. Ann Rheum Dis 2011 0.92
55 Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors. Clin Infect Dis 2008 0.90
56 Factors associated with post-seasonal serological titer and risk factors for infection with the pandemic A/H1N1 virus in the French general population. PLoS One 2013 0.90
57 Hepatitis e virus infection in sheltered homeless persons, france. Emerg Infect Dis 2012 0.89
58 Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease. Inflamm Bowel Dis 2012 0.88
59 Detection of independent associations in a large epidemiologic dataset: a comparison of random forests, boosted regression trees, conventional and penalized logistic regression for identifying independent factors associated with H1N1pdm influenza infections. BMC Med Res Methodol 2014 0.88
60 2009 A(H1N1) seroconversion rates and risk factors among the general population in Vientiane Capital, Laos. PLoS One 2013 0.87
61 Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey. Ann Rheum Dis 2012 0.87
62 Nationwide surveillance of 18 respiratory viruses in patients with influenza-like illnesses: a pilot feasibility study in the French Sentinel Network. J Med Virol 2011 0.86
63 Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccination. J Immunol 2013 0.84
64 Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV-hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 Study. Antivir Ther 2009 0.84
65 Effect of antiviral treatment on serum markers of liver fibrosis in HIV-hepatitis C virus-coinfected patients: the Fibrovic 2 Study - ANRS HC02. Antivir Ther 2009 0.84
66 Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: the EPIB 2008 study. J Hepatol 2010 0.82
67 Age distribution of cases and deaths during the 1889 influenza pandemic. Vaccine 2011 0.80
68 Field seasonal influenza vaccine effectiveness: evaluation of the screening method using different sources of data during the 2010/2011 French influenza season. Hum Vaccin Immunother 2013 0.80
69 Effectiveness of hepatitis B rapid tests toward linkage-to-care: results of a randomized, multicenter study. Eur J Gastroenterol Hepatol 2016 0.80
70 Risk perception and priority setting for intervention among hepatitis C virus and environmental risks: a cross-sectional survey in the Cairo community. BMC Public Health 2010 0.79
71 Simultaneous investigation of influenza and enteric viruses in the stools of adult patients consulting in general practice for acute diarrhea. Virol J 2012 0.79
72 Representations of influenza and influenza-like illness in the community--a qualitative study. BMC Fam Pract 2013 0.78
73 Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapy. J Hepatol 2008 0.78
74 Targeted vs. systematic early antiviral treatment against A(H1N1)v influenza with neuraminidase inhibitors in patients with influenza-like symptoms: clinical and economic impact. PLoS Curr 2009 0.78
75 Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin. AIDS 2008 0.78
76 Contribution of genome-wide association studies to scientific research: a bibliometric survey of the citation impacts of GWAS and candidate gene studies published during the same period and in the same journals. PLoS One 2012 0.78
77 A short-term, multicomponent infection control program in nursing homes: a cluster randomized controlled trial. J Am Med Dir Assoc 2012 0.78
78 High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART? AIDS 2007 0.78
79 Determinants of individuals' risks to 2009 pandemic influenza virus infection at household level amongst Djibouti city residents--a CoPanFlu cross-sectional study. Virol J 2014 0.78
80 Assessment of healthcare worker influenza vaccination program in French geriatric wards: a cluster-randomized controlled trial. Aging Clin Exp Res 2009 0.78
81 Risk factors of pandemic influenza A/H1N1 in a prospective household cohort in the general population: results from the CoPanFlu-France cohort. Influenza Other Respir Viruses 2014 0.77
82 Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment. Clin Infect Dis 2005 0.77
83 Diagnosis scoring for clinical identification of children with heterozygous familial hypercholesterolemia. J Pediatr Gastroenterol Nutr 2009 0.77
84 Characterization of pandemic influenza immune memory signature after vaccination or infection. J Clin Invest 2014 0.77
85 Risk of melanoma in patients who receive thiopurines for inflammatory bowel disease is not increased. Am J Gastroenterol 2012 0.76
86 Liver fibrosis: screening is not staging. J Hepatol 2009 0.76
87 The influenza A (H1N1) pandemic in Reunion Island: knowledge, perceived risk and precautionary behaviour. BMC Infect Dis 2013 0.76
88 Response to anti-HCV therapy in HIV-HCV-coinfected patients: does the lipid profile really have an effect? Antivir Ther 2010 0.76
89 Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccination. Vaccine 2003 0.76
90 Bedside rapid flu test and zanamivir prescription in healthy working adults: a cost-benefit analysis. Pharmacoeconomics 2003 0.76
91 Heterosubtypic immunity to influenza: right hypothesis, wrong comparison. J Infect Dis 2006 0.75
92 Comparing Patients' Opinions on the Hospital Discharge Process Collected With a Self-Reported Questionnaire Completed Via the Internet or Through a Telephone Survey: An Ancillary Study of the SENTIPAT Randomized Controlled Trial. J Med Internet Res 2015 0.75
93 Economic evaluations of neuraminidase inhibitors to control influenza. Expert Rev Pharmacoecon Outcomes Res 2003 0.75
94 Does nonadherence to local recommendations for empirical antibiotic therapy on admission to the intensive care unit have an impact on in-hospital mortality? Ther Clin Risk Manag 2009 0.75
95 Viral pneumonia and respiratory sepsis: association, causation, or it depends? Crit Care Med 2007 0.75
96 WTW--an algorithm for identifying "who transmits to whom" in outbreaks of interhuman transmitted infectious agents. J Am Med Inform Assoc 2010 0.75
97 Gamma glutamyl transferase elevation in HIV/Hepatitis C virus-coinfected patients during interferon-ribavirin combination therapy. J Acquir Immune Defic Syndr 2009 0.75
98 "If you have the flu symptoms, your asymptomatic spouse may better answer the willingness-to-pay question". Evidence from a double-bounded dichotomous choice model with heterogeneous anchoring. J Health Econ 2009 0.75
99 Immune activation, smoking, and vaccine response. AIDS 2017 0.75
100 Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patients. AIDS 2008 0.75
101 Risk factors for acute liver enzyme abnormalities in HIV-hepatitis B virus-coinfected patients on antiretroviral therapy. Antivir Ther 2007 0.75
102 Liver-FibroSTARD checklist and glossary: tools for standardized design and reporting of diagnostic accuracy studies of liver fibrosis tests. Clin Chem Lab Med 2015 0.75
103 Integrating the applicability rate into the performance evaluation of noninvasive staging of liver fibrosis: a step towards a change from the "accuracy" to the "clinical" paradigm. Clin Res Hepatol Gastroenterol 2011 0.75